ZR2 BIOENERGY [ZR2] vs Ghcl [GHCL] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: ZR2 BIOENERGY LIMITED wins in 2 metrics, Ghcl Ltd. wins in 15 metrics, with 1 ties. Ghcl Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | ZR2 BIOENERGY LIMITED | Ghcl Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 562.15 | 9.54 | Ghcl Ltd. |
| Price-to-Book Ratio | 0.39 | 1.33 | ZR2 BIOENERGY LIMITED |
| Debt-to-Equity Ratio | 0.00 | 2.66 | Tie |
| PEG Ratio | -3.97 | -0.31 | Ghcl Ltd. |
| EV/EBITDA | -57.90 | 5.10 | Ghcl Ltd. |
| Profit Margin (TTM) | 4,570.15% | 16.60% | ZR2 BIOENERGY LIMITED |
| Operating Margin (TTM) | -52.51% | 17.17% | Ghcl Ltd. |
| EBITDA Margin (TTM) | N/A | 17.17% | N/A |
| Return on Equity | 0.06% | 17.89% | Ghcl Ltd. |
| Return on Assets (TTM) | 0.06% | 14.91% | Ghcl Ltd. |
| Free Cash Flow (TTM) | $-884.40M | $3.23B | Ghcl Ltd. |
| Dividend Yield | 0.02% | 1.97% | Ghcl Ltd. |
| 1-Year Return | -63.41% | -25.88% | Ghcl Ltd. |
| Price-to-Sales Ratio (TTM) | 2,694.93 | 1.53 | Ghcl Ltd. |
| Enterprise Value | $386.09M | $37.40B | Ghcl Ltd. |
| EV/Revenue Ratio | 1,920.87 | 1.22 | Ghcl Ltd. |
| Gross Profit Margin (TTM) | N/A | 42.51% | N/A |
| Revenue per Share (TTM) | $0 | $321 | Ghcl Ltd. |
| Earnings per Share (Diluted) | $0.27 | $53.16 | Ghcl Ltd. |
| Beta (Stock Volatility) | 0.42 | -0.42 | Ghcl Ltd. |
ZR2 BIOENERGY LIMITED vs Ghcl Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| ZR2 BIOENERGY LIMITED | 4.13% | 4.17% | 1.52% | 8.11% | -52.68% | -43.20% |
| Ghcl Ltd. | -0.92% | -4.42% | -16.17% | -3.70% | -27.70% | -21.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| ZR2 BIOENERGY LIMITED | -63.41% | -67.20% | -67.20% | -67.20% | -67.20% | -67.20% |
| Ghcl Ltd. | -25.88% | -6.75% | 66.32% | 167.15% | 1,049.75% | 177.09% |
Performance & Financial Health Analysis: ZR2 BIOENERGY LIMITED vs Ghcl Ltd.
| Metric | ZR2 | GHCL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹514.63M | ₹46.18B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 627 | 120,135 |
| 90 Day Avg. Volume | 1,113 | 157,777 |
| Last Close | ₹149.95 | ₹442.65 |
| 52 Week Range | ₹90.00 - ₹437.00 | ₹419.00 - ₹667.20 |
| % from 52W High | -65.69% | -33.66% |
| All-Time High | ₹437.00 (Jul 11, 2025) | ₹779.00 (Jan 27, 2025) |
| % from All-Time High | -65.69% | -43.18% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | -0.03% |
| Quarterly Earnings Growth | N/A | -0.37% |
| Financial Health | ||
| Profit Margin (TTM) | 45.70% | 0.17% |
| Operating Margin (TTM) | -0.53% | 0.17% |
| Return on Equity (TTM) | 0.00% | 0.18% |
| Debt to Equity (MRQ) | 0.00 | 2.66 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹392.10 | ₹380.30 |
| Cash per Share (MRQ) | ₹51.76 | ₹119.25 |
| Operating Cash Flow (TTM) | ₹310.34M | ₹8.25B |
| Levered Free Cash Flow (TTM) | ₹902,000 | ₹6.24B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.02% | 1.97% |
| Last 12-Month Dividend | ₹0.10 | ₹12.00 |
Valuation & Enterprise Metrics Analysis: ZR2 BIOENERGY LIMITED vs Ghcl Ltd.
| Metric | ZR2 (Apr 24, 2026) | GHCL (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 562.15 | 9.54 |
| Forward P/E | N/A | 7.70 |
| PEG Ratio | -3.97 | -0.31 |
| Price to Sales (TTM) | 2,694.93 | 1.53 |
| Price to Book (MRQ) | 0.39 | 1.33 |
| Market Capitalization | ||
| Market Capitalization | ₹514.63M | ₹46.18B |
| Enterprise Value | ₹386.09M | ₹37.40B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1,920.87 | 1.22 |
| Enterprise to EBITDA | -57.90 | 5.10 |
| Risk & Other Metrics | ||
| Beta | 0.42 | -0.42 |
| Book Value per Share (MRQ) | ₹392.10 | ₹380.30 |
Financial Statements Comparison: ZR2 BIOENERGY LIMITED vs Ghcl Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ZR2 (2025) | GHCL (2025) |
|---|---|---|
| Revenue/Sales | 14.95M | 31.76B |
| Cost of Goods Sold | 12.56M | 17.58B |
| COGS % of Revenue | 84.0% | 55.3% |
| Gross Profit | 2.39M | 14.18B |
| Gross Margin | 16.0% | 44.7% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -3.21M | 7.68B |
| Operating Margin | -21.5% | 24.2% |
| EBITDA | 2.28M | 9.20B |
| EBITDA Margin | 15.2% | 29.0% |
| Pre-Tax Income | 2.02M | 8.36B |
| Pre-Tax Income % of Revenue | 13.5% | 26.3% |
| Income Tax | 1.12M | 2.12B |
| Income Tax % of Revenue | 7.5% | 6.7% |
| Net Income (Profit) | 902,000 | 6.24B |
| Profit Margin | 6.0% | 19.6% |
Balance Sheet & Liquidity Metrics
| Metric | ZR2 (2025) | GHCL (2025) |
|---|---|---|
| Cash & Equivalents | 190.94M | 986.30M |
| Total Current Assets | 199.09M | 19.54B |
| Total Current Assets % of Revenue | 1,332.1% | 61.5% |
| Total Current Liabilities | 1.57M | 3.68B |
| Total Current Liabilities % of Revenue | 10.5% | 11.6% |
| Long-Term Debt | N/A | 805.80M |
| Long-Term Debt % of Revenue | 0.0% | 2.5% |
| Total Shareholders Equity | 1.39B | 34.89B |
| Retained Earnings | 29.78M | 33.16B |
| Retained Earnings % of Revenue | 199.2% | 104.4% |
| Property, Plant & Equipment | 4.99M | 989.00M |
Cash Flow Statement Comparison
| Metric | ZR2 (2025) | GHCL (2025) |
|---|---|---|
| Operating Cash Flow | 310.34M | 8.25B |
| Operating Cash Flow % of Revenue | 2,076.6% | 26.0% |
| Capital Expenditures | -1.19B | -3.02B |
| Free Cash Flow | -884.40M | 3.23B |
| FCF Margin | -5,917.7% | 10.2% |
| Debt Repayment | -220.09M | -994.30M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ZR2 | GHCL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 3.57M | 91.93M |
| Float Shares | 2.93M | 63.12M |
| % Held by Insiders | 80.48% | 39.72% |
| % Held by Institutions | 0.00% | 21.54% |
| % Held by Public | 19.52% | 38.74% |
Dividend Analysis & Yield Comparison: ZR2 BIOENERGY LIMITED vs Ghcl Ltd.
| Metric | ZR2 | GHCL |
|---|---|---|
| Last 12-Month Dividend | ₹0.10 | ₹12.00 |
| Last 12-Month Dividend Yield | 0.02% | 1.97% |
| 3-Year Avg Annual Dividend | ₹0.03 | ₹13.83 |
| 3-Year Avg Dividend Yield | 0.02% | 2.50% |
| 3-Year Total Dividends | ₹0.10 | ₹41.50 |
| Ex-Dividend Date | Sep 10, 2025 | Jul 17, 2025 |